Restoring Trust in the FDA

The Greenwall Foundation convened a group of bioethics experts who explored recent issues and controversies surrounding the U.S. Food and Drug Administration, such as the agency’s approval of the Alzheimer’s drug Aduhelm, the role of advisory committees, tobacco regulation, COVID-19 vaccine approvals, and more. With moderator Adam Feuerstein, senior writer for STAT news, the panelists also explored what is needed to restore trust in the FDA. This panel marked the 20th Anniversary of The Greenwall Foundation’s flagship Faculty Scholars Program.